vs
Phathom Pharmaceuticals, Inc.（PHAT）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
Phathom Pharmaceuticals, Inc.的季度营收约是RBB Bancorp的1.8倍（$57.6M vs $32.3M），Phathom Pharmaceuticals, Inc.同比增速更快（94.1% vs 12.6%），RBB Bancorp自由现金流更多（$42.6M vs $-167.0M）
Phathom Pharmaceuticals是一家临床阶段生物制药公司，专注于研发和商业化胃肠道疾病的创新疗法，其核心候选产品针对酸相关疾病、炎症性肠病等适应症，主要服务北美及欧洲地区的患者群体。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
PHAT vs RBB — 直观对比
营收规模更大
PHAT
是对方的1.8倍
$32.3M
营收增速更快
PHAT
高出81.5%
12.6%
自由现金流更多
RBB
多$209.6M
$-167.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.6M | $32.3M |
| 净利润 | — | $10.2M |
| 毛利率 | 86.7% | — |
| 营业利润率 | — | 39.5% |
| 净利率 | — | 31.5% |
| 营收同比 | 94.1% | 12.6% |
| 净利润同比 | 71.6% | 132.1% |
| 每股收益（稀释后） | — | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PHATRBB
| Q4 25 | $57.6M | $32.3M | ||
| Q3 25 | $49.5M | $32.6M | ||
| Q2 25 | $39.5M | $35.8M | ||
| Q1 25 | $28.5M | $28.5M | ||
| Q4 24 | $29.7M | $28.7M | ||
| Q3 24 | $16.4M | $30.3M | ||
| Q2 24 | $7.3M | $27.5M | ||
| Q1 24 | — | $28.2M |
净利润PHATRBB
| Q4 25 | — | $10.2M | ||
| Q3 25 | $-30.0M | $10.1M | ||
| Q2 25 | $-75.8M | $9.3M | ||
| Q1 25 | $-94.3M | $2.3M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | $-85.6M | $7.0M | ||
| Q2 24 | $-91.4M | $7.2M | ||
| Q1 24 | — | $8.0M |
毛利率PHATRBB
| Q4 25 | 86.7% | — | ||
| Q3 25 | 87.5% | — | ||
| Q2 25 | 87.2% | — | ||
| Q1 25 | 86.9% | — | ||
| Q4 24 | 87.1% | — | ||
| Q3 24 | 85.6% | — | ||
| Q2 24 | 81.2% | — | ||
| Q1 24 | — | — |
营业利润率PHATRBB
| Q4 25 | — | 39.5% | ||
| Q3 25 | -30.8% | 40.7% | ||
| Q2 25 | -151.7% | 36.1% | ||
| Q1 25 | -276.5% | 11.2% | ||
| Q4 24 | — | 17.6% | ||
| Q3 24 | -433.0% | 31.6% | ||
| Q2 24 | -1055.4% | 35.6% | ||
| Q1 24 | — | 39.9% |
净利率PHATRBB
| Q4 25 | — | 31.5% | ||
| Q3 25 | -60.5% | 31.2% | ||
| Q2 25 | -191.9% | 26.1% | ||
| Q1 25 | -330.7% | 8.0% | ||
| Q4 24 | — | 15.3% | ||
| Q3 24 | -523.3% | 23.1% | ||
| Q2 24 | -1248.6% | 26.4% | ||
| Q1 24 | — | 28.4% |
每股收益（稀释后）PHATRBB
| Q4 25 | — | $0.59 | ||
| Q3 25 | $-0.41 | $0.59 | ||
| Q2 25 | $-1.05 | $0.52 | ||
| Q1 25 | $-1.31 | $0.13 | ||
| Q4 24 | — | $0.26 | ||
| Q3 24 | $-1.32 | $0.39 | ||
| Q2 24 | $-1.56 | $0.39 | ||
| Q1 24 | — | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $130.0M | $212.3M |
| 总债务越低越好 | $209.1M | $119.9M |
| 股东权益账面价值 | $-438.2M | $523.4M |
| 总资产 | $259.1M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资PHATRBB
| Q4 25 | $130.0M | $212.3M | ||
| Q3 25 | $135.2M | $234.9M | ||
| Q2 25 | $149.6M | $191.9M | ||
| Q1 25 | $212.3M | $238.8M | ||
| Q4 24 | $297.3M | $257.7M | ||
| Q3 24 | $334.7M | $349.4M | ||
| Q2 24 | $276.2M | $252.8M | ||
| Q1 24 | — | — |
总债务PHATRBB
| Q4 25 | $209.1M | $119.9M | ||
| Q3 25 | $207.1M | $119.8M | ||
| Q2 25 | $205.1M | $119.7M | ||
| Q1 25 | $203.2M | $119.6M | ||
| Q4 24 | $201.4M | $119.5M | ||
| Q3 24 | $175.7M | $119.4M | ||
| Q2 24 | $174.4M | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益PHATRBB
| Q4 25 | $-438.2M | $523.4M | ||
| Q3 25 | $-422.5M | $514.3M | ||
| Q2 25 | $-405.8M | $517.7M | ||
| Q1 25 | $-338.4M | $510.3M | ||
| Q4 24 | $-253.6M | $507.9M | ||
| Q3 24 | $-187.1M | $509.7M | ||
| Q2 24 | $-233.8M | $511.3M | ||
| Q1 24 | — | $514.0M |
总资产PHATRBB
| Q4 25 | $259.1M | $4.2B | ||
| Q3 25 | $240.3M | $4.2B | ||
| Q2 25 | $250.2M | $4.1B | ||
| Q1 25 | $294.2M | $4.0B | ||
| Q4 24 | $378.3M | $4.0B | ||
| Q3 24 | $387.0M | $4.0B | ||
| Q2 24 | $319.4M | $3.9B | ||
| Q1 24 | — | $3.9B |
负债/权益比PHATRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-166.8M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-167.0M | $42.6M |
| 自由现金流率自由现金流/营收 | -290.0% | 131.8% |
| 资本支出强度资本支出/营收 | 0.4% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-328.9M | $73.5M |
8季度趋势，按日历期对齐
经营现金流PHATRBB
| Q4 25 | $-166.8M | $43.4M | ||
| Q3 25 | $-14.1M | $2.1M | ||
| Q2 25 | $-62.7M | $21.7M | ||
| Q1 25 | $-84.9M | $7.8M | ||
| Q4 24 | $-266.8M | $58.5M | ||
| Q3 24 | $-63.6M | $24.5M | ||
| Q2 24 | $-70.7M | $11.7M | ||
| Q1 24 | — | $4.8M |
自由现金流PHATRBB
| Q4 25 | $-167.0M | $42.6M | ||
| Q3 25 | $-14.1M | $1.8M | ||
| Q2 25 | $-62.8M | $21.6M | ||
| Q1 25 | $-84.9M | $7.6M | ||
| Q4 24 | $-266.9M | $57.7M | ||
| Q3 24 | $-63.6M | $24.2M | ||
| Q2 24 | $-70.8M | $11.5M | ||
| Q1 24 | — | $4.7M |
自由现金流率PHATRBB
| Q4 25 | -290.0% | 131.8% | ||
| Q3 25 | -28.6% | 5.4% | ||
| Q2 25 | -159.0% | 60.2% | ||
| Q1 25 | -297.9% | 26.7% | ||
| Q4 24 | -899.8% | 201.0% | ||
| Q3 24 | -389.0% | 80.0% | ||
| Q2 24 | -966.2% | 42.0% | ||
| Q1 24 | — | 16.6% |
资本支出强度PHATRBB
| Q4 25 | 0.4% | 2.5% | ||
| Q3 25 | 0.1% | 1.1% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.5% | 2.7% | ||
| Q3 24 | 0.3% | 0.8% | ||
| Q2 24 | 0.6% | 0.5% | ||
| Q1 24 | — | 0.5% |
现金转化率PHATRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
